The notice, which applies to drops marketed under several generic store brands including CVS Health, Rite Aid and Target’s Up & Up, warns that the eyedrops could contain dangerous bacteria.
While the FDA has not received any infection reports from consumers, the agency is recommending that manufacturers pull all potentially contaminated products from store shelves.
The FDA has urged consumers who used potentially contaminated eye drops to discard them. A full list of recalled products can be found here.
In March, Pharmedica and Apotex voluntarily recalled several lots of drops due to contamination risks.
In addition, the CDC began investigating drug-resistant pseudomonas aeruginosa strains never before reported in the U.S. in January that have since been linked to Global Pharma Healthcare’s Artificial Tears Lubricant Eye Drops, distributed by EzriCare and Delsam Pharma.
The rare bacteria was linked to dozens of infections, 14 cases of vision loss, four eye removals and three patient deaths.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.